home
HOME 

  WELCOME
 
The Mount Sinai Community Clinical Oncology Program (MSCCOP) is a nonprofit community-based program committed to providing novel clinical research to cancer treatment patients and to healthy individuals who may be at risk for cancer.

CCOP is a comprehensive organized clinical trials mechanism for disseminating the latest cancer prevention and treatment research findings to the community level. The aim of the program is to provide cancer patients with access to NCI-sponsored cancer treatment trials and up to date cancer management in patients’ own communities. The program increases the number of patients and physicians who can participate in clinical trials operated at major research centers, and allows scientists to conduct large-scale cancer prevention and control studies. read more ...

 
Newest Protocols
Stage IIB, IIIC, or IV (NCCTG N0733 ): RANDOMIZED PHASE II TRIAL OF CAPECITABINE AND LAPATINIB WITH OR WITHOUT IMC-A12 IN PATIENTS...
Cat: Breast (11/16/2011)
Neo-Adjuvant (SWOG S0800): A RANDOMIZED PHASE II TRIAL OF PACLITAXEL ALBUMIN-STABILIZED NANOPARTICLE FORMULATION, DOXO...
Cat: Breast (09/23/2011)
CALGB 70806 (Breast): VITAMIN D AND BREAST CANCER BIOMARKERS
Cat: Cancer Control/Prevention (09/23/2011)
Latest Announcements
MEL0107 (CLOSED TO ACCRUAL)
RTOG 0825 (CLOSED TO ACCRUAL)
CALGB 50401 (CLOSED TO ACCRUAL)
more ...
 



©2004 MSCCOP & Mount Sinai Medical Center